Colorectal News and Research

RSS

New drug designed to stop cancer from spreading by preventing mitosis

TGen Clinical Research Services at Scottsdale Healthcare (TCRS) is the world's first clinical trials site for a new drug designed to halt cancer cell division.

9 Dec 2009

People living in deprived neighborhoods more likely to die from cancer and heart disease

Regardless of an individual's dietary and lifestyle risk factors, living in a poorer or more socioeconomically deprived neighborhood may increase a person's risk for death, according to data presented at the American Association for Cancer Research Conference on Frontiers in Cancer Prevention Research, held Dec. 6-9, 2009.

9 Dec 2009

Colon Cancer Alliance's statement regarding a new report on drop in colorectal cancer

A recent study by the Centers for Disease Control and Prevention (CDC), American Cancer Society (ACS), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) highlighting that the death rate from colorectal cancer over the last decade dropped nearly 20 percent and that by 2020 could be cut in half is welcomed news.

9 Dec 2009

Transgenomic's SURVEYOR Scan K-RAS mutation detection kit launched

Transgenomic, Inc. announced today the launch of its SURVEYOR Scan K-RAS kit, the first in a family of mutation detection kits the company plans to offer featuring its proprietary SURVEYOR Nuclease and WAVE® HS DHPLC platform. SURVEYOR Scan technology is a novel approach to mutation detection that uses a PCR amplification reaction and hybridization to form heteroduplex DNA molecules in samples with K-RAS mutation.

9 Dec 2009

Consumer reports details the screening tests that may be unneccesary

Consumer Reports/The Washington Post: "Many Americans -- and their doctors -- seem to think that better health means more health care, including as many screening tests as possible. But many researchers are questioning that notion, saying that some common screening tests are unproven and can not only waste your time and money but also cause more harm than good."

8 Dec 2009

Erbitux gaining market share of Avastin in Europe

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite its dominance in early lines of metastatic colorectal cancer treatment, Roche/Chugai's Avastin will face increasing competition from Bristol-Myers Squibb/Eli Lilly/Merck KGaA's Erbitux in Germany, France and Spain.

8 Dec 2009

Long-chain omega-3 fatty acids can prevent colorectal cancer

Long-chain omega-3 fatty acids, primarily found in fish and seafood, may have a role in colorectal cancer prevention, according to results presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held Dec. 6-9, 2009, in Houston.

8 Dec 2009

U.S. cancer rates continue to decline in racial and ethnic populations

Good news in the fight against cancer! A new report from leading health and cancer organizations shows national cancer rates continue to decline.

8 Dec 2009

Selenium-based antioxidant compound reduces risk of colorectal cancer

Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel — called colorectal metachronous adenomas — in people who previously had colorectal polyps removed.

8 Dec 2009

New Center for Digestive Care to care for all aspects of digestive disease

The Center for Digestive Care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has been established with a mission to provide high-quality patient care, research and education for all aspects of digestive disease.

4 Dec 2009

KFDA approves RPC's Onko-Sure in Vitro Diagnostic cancer test

US-based pharmaceutical company Radient Pharmaceuticals Corporation (RPC) announced today the Korean Food & Drug Administration (KFDA) has approved RPC's Onko-Sure™ in Vitro Diagnostic cancer test for routine clinical testing and government reimbursement throughout Korea.

4 Dec 2009

CT imaging after chemotherapy with bevacizumab may help predict overall survival

Preliminary research suggests that criteria based on computed tomography (CT) imaging of changes in tumors from colorectal liver metastases after chemotherapy with the drug bevacizumab may have the potential to predict overall survival, according to a study in the December 2 issue of JAMA.

3 Dec 2009

New study links cigarette smoking with colorectal cancer

New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for other risk factors.

3 Dec 2009

Cancer Prevention Research Conference highlights new research on cancer

The American Association for Cancer Research Frontiers in Cancer Prevention Research Conference will focus on the latest biological, medical and social research behind cancer prevention.

2 Dec 2009

CT imaging combined with Avastin may predict overall survival in metastatic colorectal cancer

Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, according to research from The University of Texas M. D. Anderson Cancer Center.

2 Dec 2009

Surgeons remove rectal mass using innovative surgical approach

Performing surgical operations without leaving scars has ceased to be a chimera and has become a reality. This is demonstrated by the recent surgical advances made using NOTES (Natural Orifice Transluminal Endoscopy Surgery), an innovative surgical approach that allows surgical access using the body's natural orifices.

2 Dec 2009

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

New figures show there was a steady decline in cancer deaths in the European Union between 1990-1994 and 2000-2004.

1 Dec 2009

Researchers devise a way to deliver right therapy directly to tumors using aptamers

Finding and treating a tumor without disturbing normal tissue presents challenges - sometimes the most effective therapies can be invasive and harsh.

1 Dec 2009

Sentinelle Medical's Aegis Navigation MRI and ultrasound imaging system showcased at RSNA 2009

Sentinelle Medical Inc., a leading manufacturer of MRI coils and advanced visualization software is demonstrating a number of innovative new works-in-progress, including MRI and ultrasound co-registration offering at RSNA 2009.

30 Nov 2009

Cell Therapeutics' platinum-based anti-tumor compounds demonstrate stronger anti-tumor potency

Cell Therapeutics, Inc. (CTI) announced today that its new class of platinum-based anti-tumor compounds, termed bis-platinates, demonstrated a stronger anti-tumor potency and activity compared to currently available platinum-based compounds as well as the ability to overcome cisplatin-resistance in cancer cell lines.

30 Nov 2009

Colorectal News and Research

New drug designed to stop cancer from spreading by preventing mitosis

People living in deprived neighborhoods more likely to die from cancer and heart disease

Colon Cancer Alliance's statement regarding a new report on drop in colorectal cancer

Transgenomic's SURVEYOR Scan K-RAS mutation detection kit launched

Consumer reports details the screening tests that may be unneccesary

Erbitux gaining market share of Avastin in Europe

Long-chain omega-3 fatty acids can prevent colorectal cancer

U.S. cancer rates continue to decline in racial and ethnic populations

Selenium-based antioxidant compound reduces risk of colorectal cancer

New Center for Digestive Care to care for all aspects of digestive disease

KFDA approves RPC's Onko-Sure in Vitro Diagnostic cancer test

CT imaging after chemotherapy with bevacizumab may help predict overall survival

New study links cigarette smoking with colorectal cancer

Cancer Prevention Research Conference highlights new research on cancer

CT imaging combined with Avastin may predict overall survival in metastatic colorectal cancer

Surgeons remove rectal mass using innovative surgical approach

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

Researchers devise a way to deliver right therapy directly to tumors using aptamers

Sentinelle Medical's Aegis Navigation MRI and ultrasound imaging system showcased at RSNA 2009

Cell Therapeutics' platinum-based anti-tumor compounds demonstrate stronger anti-tumor potency

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News